The track record of the Swiss healthcare system is remarkable. The country has one of the greatest life expectancies in Europe and is believed to have the second-largest number of individuals who live to be 100. According to research by the Swiss Institute for Social and Preventive Medicine, life expectancy has grown in Switzerland by 96% for women and 98% for men since 1900. Nevertheless, there was a temporary decline in life expectancy during the 1918 influenza pandemic.
Federal law serves as the foundation for medical education in Switzerland, which normally lasts six years. The Swiss Confederation grants medical degrees to graduates of Swiss universities. They then go through specialized postgraduate training, which results in certification and the expert title. A sizable research network is also part of the Swiss healthcare system. In general, research is carried out in medical facilities all around the nation. Despite the nation’s high level of medical skill, political polarization and a small critical mass impede medical advancement.
Switzerland has maintained a remarkably low level of public debt in comparison to other nations while having a low GDP per capita. Its gross public debt was under CHF 100 billion at the beginning of 2021, or slightly more than 15% of its GDP. With a VAT rate of 3.7% for lodging services and 2.5% for essential products and services, Switzerland has one of the lowest rates in all of Europe. R&D expenditures in Switzerland total more than CHF 22.5 billion yearly or 3% of the country’s GDP.